IPI-9119

IPI-3063

IPI-504

(3'R,3'aS,6'S,6aS,6bS,7'aR,9S,12aS,12bR)-3',6',11,12b-tetramethylspiro[2,5,6,6a,6b,7,8,10,12,12a-decahydro-1H-naphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-one

Duvelisib (IPI-145, INK1197)

Eganelisib(IPI-549)

SHU9119

4-Hydrazino-5,6,7,8,9,10-hexahydrocycloocta[4,5]thieno[2,3-d]pyrimidine

5-(Chloromethyl)-7-oxo-6,7-dihydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid

5,7-Dimethyl-2,3-dihydropyrido[3,4-d]pyridazine-1,4-dione

Ethyl 4-methyl-2-(4-methyl-1,4-diazepan-1-yl)-1,3-thiazole-5-carboxylate

N-(2H-3,4'-Bi-1,2,4-triazol-5-ylmethyl)benzamide

3-(2H-3,4'-Bi-1,2,4-triazol-5-yl)propanoic acid

4-[5-(Chloromethyl)-1,2,4-oxadiazol-3-yl]benzamide

4-[5-(Chloromethyl)-1,2,4-oxadiazol-3-yl]-N,N-dimethylbenzamide

3-[5-(Chloromethyl)-1,2,4-oxadiazol-3-yl]benzamide

2-Methoxy-5-(1,2,4-oxadiazol-3-yl)benzoic acid